Related Experiment Videos
Hereditary auto-inflammatory disorders and biologics
Leigh D Church1, Sarah M Churchman, Philip N Hawkins
1Academic Unit of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, Epidemiology and Cancer Research, University of Leeds, Leeds, UK.
Springer Seminars in Immunopathology
|June 2, 2006
Summary
Auto-inflammatory disorders involve recurrent inflammation without T cells or auto-antibodies. Genetic insights into innate immunity are advancing treatments, though challenges remain for conditions like HIDS and TRAPS.
Area of Science:
- Immunology
- Genetics
- Rheumatology
Background:
- Auto-inflammatory disorders are characterized by recurrent systemic inflammation.
- These conditions lack T cell involvement or auto-antibody production.
- Hereditary periodic fever syndromes are prototypic auto-inflammatory diseases.
Purpose of the Study:
- To explore genetic insights into innate immunity in auto-inflammatory disorders.
- To discuss the role of DNA analysis in clinical characterization.
- To evaluate current and future therapeutic targets within the immune cascade.
Main Methods:
- Review of genetic studies on hereditary periodic fever syndromes.
- Analysis of molecular aetiopathogenesis.
- Evaluation of biologic response modifiers, including TNF and IL-1beta inhibitors.
Main Results:
- Genetic studies have provided significant insights into innate immunity.
- Biologic therapies have improved outcomes for some disorders.
- Effective therapies are still lacking for hyperimmunoglobulinaemia-D with periodic fever syndrome (HIDS) and some TNF-receptor associated periodic syndrome (TRAPS) cases.
Conclusions:
- Elucidation of molecular mechanisms offers potential for targeted therapies.
- TNF blockade is not universally effective for TRAPS, with some cases showing exacerbation.
- Further research is needed to address therapeutic challenges in specific auto-inflammatory disorders.